QBIN has received a request for collaboration to evaluate an artificial intelligence solution for bioimaging by Korean medical company, Heuron.
Vectis Corporation represents a group of Korean medical companies to increase their reach abroad. Their advisory activities are part of an official programme initiated by the Ministry of Health and Welfare (mohw.go.kr) and supported by the Korea Health Industry Development Institute (KHIDI).
Under this program, Vectis would like to propose to members of QBIN to evaluate an artificial intelligence solution for bioimaging of one of these companies, Heuron Co.,Ltd (iheuron.com). Below are three documents describing the company. Of importance, it has obtained FDA 510(k) and EC certification.
The goal is to help Heuron develop collaborative agreements with research institutes in bioimaging located outside Korea.
For more information, please contact:
CEO, Vectis Corporation, Ltd.